Research Studies

Clinical Trials

Trial PI/Additional Investigators ClinicalTrials.gov Identifier
FALKON: Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).  Edward Hsiao NCT05039515
Rollover Study; Multicentre, Phase III, Open-label Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years with Fibrodysplasia Ossificans Progressiva (FOP)  Edward Hsiao NCT05027802
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtylast)  Chienying Liu  NCT04490915
T1D Exchange Quality Improvement Collaborative and COVID-19 Population Study
(T1D Exchange) 		 Umesh Masharani, Jenise Wong  NCT04629586

Investigator-Initiated Studies 

Trial PI/Additional Investigators ClinicalTrials.gov Identifier
Human Biospecimen Tissue Bank for the Study of Molecular Mechanisms of Hormonal Disorders (Endocrine Biobank) Endocrine Division-wide N/A
The Gut Microbiome in Human Endocrine diseases Edward Hsiao N/A
The UCSF Biospecimens and Skeletal Tissues for Rare and Orphan Disease Genetics (BSTROnG Biobank) Edward Hsiao,
Kelly Wentworth		 N/A
New onset type 1 diabetes study  Mark Anderson,
Zoe Quandt		 N/A
Autoimmune polyendocrine syndrome 1 (APS1) study Mark Anderson,
Zoe Quandt		 N/A
Atypical Diabetes study (in collaboration with U Chicago) Mark Anderson,
Zoe Quandt		 N/A
Immune Checkpoint Inhibitor study Mark Anderson,
Zoe Quandt		 N/A
Inflammation, Diabetes, Ethnicity and Obesity (IDEO) Cohort Diana Alba,
Suneil Koliwad		 NCT03022682
Immunologic and fat-associated predictors of insulin resistance in treated HIV   Suneil Koliwad, Peter Hunt, Diana Alba